PCOL 406 Exam 2 Flashcards

1
Q

Nonselective a-blockers meds

A

phenoxybenzamine

phentolamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Selective a1-blockers meds

A

doxazosin
tamsulosin
alfuzosin
silodosin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Nonselective B-blockers meds

A

propranolol
timolol
pindolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Selective B1-blockers meds

A

atenolol
esmolol
metoprolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

a- and B- Adrenoceptor Antagonists

A

carvedilol

labetalol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Alfuzosin, tamsulosin mechanism of action

A

competitive a1-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alfuzosin, tamsulosin pharmacological effects

A

relax bladder, urethral and prostate smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Alfuzosin, tamsulosin clinical use

A

urinary symptoms caused by benign prostatic hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Doxazosin, prazosin, terazosin mechanism of action

A

competitive a1-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Doxazosin, prazosin, terazosin pharmacological effects

A
  • causes vasodilation and decreases blood pressure

- relax bladder, urethral, and prostate smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Doxazosin, prazosin, terazosin clinical use

A
  • hypertension

- urinary symptoms cause by benign prostatic hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Phenoxybenzamine mechanism of action

A

noncompetitive a1- and a2- blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Phenoxybenzamine pharmacological effect

A

causes vasodilation and decreases blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Phenoxybenzamine clinical use

A

hypertension in pheochromocytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Phentolamine mechanism of action

A

competitive a1- and a2- blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Phentolamine pharmacological effect

A
  • causes vasodilation

- decreases vascular resistance and blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Phentolamine clinical use

A
  • hypertension in pheochromocytoma

- treat necrosis and ischemia after injection of an a-adrenoceptor agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Acebutolol mechanism of action

A

B1-blocker with ISA and MSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Acebutolol pharmacological effect

A

decreases cardiac rate, output, O2 demand, AV node conduction, and blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Acebutolol clinical use

A
  • hypertension

- cardiac dysrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Atenolol mechanism of action

A

B1-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Atenolol pharmacological effect

A

decreases cardiac rate, output, O2 demand, AV node conduction, and blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Atenolol clinical use

A
  • hypertension
  • angina pectoris
  • acute myocardial infarction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Betaxolol mechanism of action

A

B1-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Betaxolol pharmacological effect

A
  • decreases cardiac rate, output, O2 demand, AV node conduction, and blood pressure
  • decreases intraocular pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Betaxolol clinical use

A

glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Bisoprolol mechanism of action

A

B1-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Bisoprolol pharmacological effect

A

decreases cardiac rate, output, O2 demand, AV node conduction, and blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Bisoprolol clinical use

A

hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Esmolol mechanism of action

A

B1-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Esmolol pharmacological effect

A

decreases cardiac rate, output, O2 demand, AV node conduction, and blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Esmolol clinical use

A

acute supraventricular tachycardia and hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Metoprolol mechanism of action

A

B1-blocker with MSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Metoprolol pharmacological effect

A

decreases cardiac rate, output, O2 demand, AV node conduction, and blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Metoprolol clinical use

A
  • hypertension
  • angina pectoris
  • acute myocardial infarction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Nadolol mechanism of action

A

B1- and B2- blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Nadolol pharmacological effect

A

decreases cardiac rate, output, O2 demand, AV node conduction, and blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Nadolol clinical use

A
  • hypertension
  • angina pectoris
  • migraine headache
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Nebivolol mechanism of action

A

B1-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Nebivolol pharmacological effect

A

decreases cardiac rate, output, O2 demand, AV node conduction, and blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Nebivolol clinical use

A

hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Pindolol mechanism of action

A

B1- and B2- blocker with ISA and MSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Pindolol pharmacological effect

A

decreases cardiac rate, output, O2 demand, AV node conduction, and blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Pindolol clinical use

A

hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Propranolol mechanism of action

A

B1- and B2- blocker with MSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Propranolol pharmacological effect

A

decreases cardiac rate, output, O2 demand, AV node conduction, and blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Propranolol clinical use

A
  • hypertension
  • angina pectoris
  • cardiac dysrhythmias
  • hypertrophic subaortic stenosis
  • essential tremor
  • migraine headache
  • acute thyrotoxicosis
  • acute myocardial infarction
  • pheochromocytoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Timolol mechanism of action

A

B1- and B2- blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Timolol pharmacological effect

A
  • decreases cardiac rate, output, O2 demand, AV node conduction, and blood pressure
  • decreases intraocular . pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Timolol clinical use

A
  • hypertension
  • acute myocardial infarction
  • migraine headache
  • glaucoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Carvedilol mechanism of action

A

B1- and B2- blocker, a1-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Carvedilol pharmacological effect

A
  • causes vasodilation
  • decreases heart rate and blood pressure in patients with hypertension
  • increases cardiac output in patients with heart failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Carvedilol clinical use

A
  • hypertension

- heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Labetalol mechanism of action

A

B1- and B2- blocker with MSA, a1-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Labetalol pharmacological effect

A
  • causes vasodilation

- decreases heart rate and blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Labetalol clinical use

A

hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Diuretics meds

A

thiazides

hydrochlorothiazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Potassium Sparing Diuretics meds

A

amiloride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Sympatholytics adrenoceptor antagonist meds

A
carvedilol
metoprolol
propranolol
atenolol 
doxazosin
metyrosine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Sympatholytics centrally acting drugs meds

A

clonidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Angiotensin-converting enzyme (ACE) inhibitors meds

A

lisinopril
benazepril
enalapril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Angiotensin receptor antagonists meds

A

losartan
candesartan
irbesartan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Direct renin inhibitor meds

A

aliskiren

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Vasodilators calcium channel blockers (CCBs) meds

A
amlodipine
diltiazem 
nifedipine 
verapamil 
hydralazine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Vasodilators Dopamine agonist meds

A

fenoldopam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Primary Hypertension

A

cannot be attributed to a specific cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Secondary Hypertension

A

results from an identifiable cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Angiotensin II

A

may cause vascular injury by activating growth factors that cause vascular smooth muscle proliferation and hypertrophy as well as fibrotic changes in the vascular wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Cardiac Output

A

product of stroke volume and heart rate, increased by sympathetic stimulation via activation of B1-adrenoceptors in the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

PVR (Peripheral Vascular Resistance)

A

determined by the resistance to blood flow through the arterioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Thiazide and loop diuretics common adverse effects

A
  • blood cell deficiencies
  • hyperlipidemia
  • hyperuricemia
  • hypokalemia
  • electrolyte changes
  • aggravation of diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Thiazide and loop diuretics common drug interactons

A
  • increase serum levels of lithium
  • hypotensive effect decreased by NSAIDs
  • augmented by ACE inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Potassium sparing diuretics common adverse effects

A

hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Potassium sparing diuretics common drug interactions

A

hyperkalemic effect increased by ACE inhibitors and potassium supplements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

a-adrenoceptor antagonists common adverse effects

A
  • dizziness
  • first dose syncope
  • fluid retention
  • orthostatic hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

a-adrenoceptor antagonists common drug interactions

A

hypotensive effect increased by B-adrenoceptor antagonists and diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Clonidine common adverse effects

A
  • dry mouth
  • fatigue
  • rebound hypertension
  • sedation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Clonidine common drug interactions

A
  • hypotensive effect decreased by tricyclic antidepressants

- sedative effect increased by CNS depressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

B-adrenoceptor antagonists common adverse effects

A
  • bradycardia
  • bronchoconstriction
  • depression
  • fatigue
  • impaired glycogenolysis
  • vivid dreams
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

B-adrenoceptor antagonists common drug interactions

A
  • cardiac depression increased by diltiazem and verapamil

- hypotensive effect decreased by NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Guanfacine common adverse effects

A
  • dry mouth
  • fatigue
  • rebound hypertension
  • sedation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Guanfacine common drug interactions

A
  • hypotensive effect decreased by tricyclic antidepressants

- sedative effect increased by CNS depressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Methyldopa common adverse effects

A
  • autoimmune hemolytic anemia
  • hepatitis
  • lupus-like syndrome
  • dry mouth
  • fatigue
  • rebound hypertension
  • sedation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Methyldopa common drug interactions

A
  • hypotensive effect increased by levodopa
  • hypotensive effect decreased by tricyclic antidepressants
  • sedative effect increased by CNS depressants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

ACE inhibitors common adverse effects

A
  • acute renal failure
  • angioedema
  • cough
  • hyperkalemia
  • metallic taste
  • neutropenia
  • rash
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

ACE inhibitors common drug interactions

A
  • increase serum levels of lithium
  • hyperkalemic effect increased by potassium-sparing diuretics and potassium supplements
  • hypotensive effect decreased by NSAIDs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Angiotensin receptor antagonists common adverse effects

A

hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Angiotensin receptor antagonists common drug interactions

A

serum levels of drug increased by cimetidine and decreased by phenobarbital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Aliskiren common adverse effects

A

hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Aliskiren common drug interactions

A
  • aliskiren reduces serum levels of furosemide

- cyclosporine increases levels of aliskiren

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

Dihydropyridine common adverse effects

A
  • dizziness
  • edema
  • gingival hyperplasia
  • headache
  • tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

Dihydropyridine common drug interactions

A

serum levels of drug increased by azole antifungal agents, cimetidine, and grapefruit juice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

Diltiazem common adverse effects

A
  • atrioventricular block
  • bradycardia
  • constipation
  • dizziness
  • edema
  • gingival hyperplasia
  • headache
  • heart failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

Diltiazem common drug interactions

A
  • increases serum levels of carbamazepine, digoxin, and theophylline
  • decreases serum levels of lithium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Verapamil common adverse effects

A
  • atrioventricular block
  • bradycardia
  • constipation
  • dizziness
  • edema
  • gingival hyperplasia
  • headache
  • heart failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

Verapamil common drug interactions

A
  • increases serum levels of carbamazepine, digoxin, and theophylline
  • decreases serum levels of lithium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

Hydralazine common adverse effects

A
  • angina
  • dizziness
  • fluid retention
  • headache
  • lupus-like syndrome
  • tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

Hydralazine common drug interactions

A

hypotensive effect decreased by NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Minoxidil common adverse effects

A
  • angina
  • dizziness
  • fluid retention
  • headache
  • hypertrichosis
  • pericardial effusion
  • tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Minoxidil common drug interactions

A

hypotensive effect decreased by NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

Nitroprusside common adverse effects

A
  • dizziness
  • headache
  • increased intracranial pressure
  • methemoglobinemia
  • thiocyanate
  • cyanide toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Nitroprusside common drug interactions

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Fenoldopam common adverse effects

A
  • headache

- nausea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

Fenoldopam common drug interactions

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

Age 65+ most preferred drugs

A

ARB, ACEI, CCB, thiazide diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

Age 65+ least preferred drugs

A

clonidine, B-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

African heritage most preferred drugs

A

thiazide diuretic, CCB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

African heritage least preferred drugs

A

B-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

Pregnant most preferred drugs

A

methyldopa, labetalol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

Pregnant least preferred drugs

A

ACEI, ARB, aliskiren

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

Angina Pectoris most preferred drugs

A

B-blocker, CCB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

Angina Pectoris least preferred drugs

A

hydralazine, minoxidil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

Myocardial infarction most preferred drugs

A

ACEI, ARB, B-blocker, aldosterone antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

Myocardial infarction least preferred drugs

A

hydralazine, minoxidil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

Congestive heart failure most preferred drugs

A

ACEI, ARB, B-blocker, thiazide or loop diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

Congestive heart failure least preferred drugs

A

verapamil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

Stroke prevention most preferred drugs

A

ARB, ACEI, CCB, thiazide diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

Kidney disease most preferred drugs

A

ACEI or ARB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

Diabetes most preferred drugs

A

ACEI, ARC, CCB, thiazide diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

Asthma most preferred drugs

A

ACEI, ARC, CCB, thiazide diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

Benign prostatic hyperplasia most preferred drugs

A

a-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

Migraine headache most preferred drugs

A

B-blocker, CCB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

Osteoporosis most preferred drugs

A

thiazide diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

Organic Nitrites and Nitrates meds

A

amyl nitrate
isosorbide dinitrate
isosorbide mononitrate
nitroglycerin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

Calcium Channel Blockers meds

A

amlodipine
nifedipine
diltiazem
verapamil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

B-Adrenoceptor Antagonists meds

A

atenolol
metoprolol
nadolol
propranolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

Other Agents meds

A

ranolazine
ivabradine
trimetazidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

Amlodipine oral bioavailability

A

75%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

Amlodipine excreted unchanged in urine

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

Amlodipine elimination half life

A

40 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

Felodipine oral bioavailability

A

20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

Felodipine excreted unchanged in urine

A

1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

Felodipine elimination half life

A

14 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

Nicardipine oral bioavailability

A

35%

135
Q

Nicardipine excreted unchanged in urine

A

1%

136
Q

Nicardipine elimination half life

A

3 hours

137
Q

Nifedipine oral bioavailability

A

60%

138
Q

Nifedipine excreted unchanged in urine

A

1%

139
Q

Nifedipine elimination half life

A

3 hours

140
Q

Nimodipine oral bioavailability

A

13%

141
Q

Nimodipine excreted unchanged in urine

A

<1%

142
Q

Nimodipine elimination half life

A

1.5 hours

143
Q

Diltiazem oral bioavailability

A

55%

144
Q

Diltiazem excreted unchanged in urine

A

3%

145
Q

Diltiazem elimination half life

A

5 hours

146
Q

Verapamil oral bioavailability

A

25%

147
Q

Verapamil excreted unchanged in urine

A

3%

148
Q

Verapamil elimination half life

A

5 hours

149
Q

Digitalis glycoside meds

A

digoxin

digoxin immune fab

150
Q

Adrenoceptor agonist meds

A

dobutamine

151
Q

Phosphodiesterase inhibitor meds

A

milrinone

152
Q

Vasodilators angiotensin inhibitors meds

A

enalapril

valsartan

153
Q

Vasodilators neprilysin inhibitor meds

A

sacubitril

154
Q

Other vasodilators

A

hydralazine
isosorbide dinitrate
nesiritide

155
Q

Beta Adrenoceptor blocker med

A

carvedilol

156
Q

Aldosterone antagonists meds

A

spironolactone

eplerenone

157
Q

Diuretic med

A

furosemide

158
Q

Digoxin cardiac effect

A

increases parasympathetic tone and decreases sympathetic tone

159
Q

Dobutamine cardiac effect

A

increases blood pressure

160
Q

Milrinone cardiac effect

A

reduces blood pressure

161
Q

ACE inhibitors cardiac effect

A

reduces blood pressure

162
Q

Hydralazine cardiac effect

A

reduces blood pressure

163
Q

Isosorbide dinitrate cardiac effect

A

reduces pulmonary congestion

164
Q

Nesiritide cardiac effect

A

reduces venous and arterial blood pressure

165
Q

Loop-acting diuretics (furosemide and others) cardiac effect

A

reduces edema and congestion

166
Q

Carvedilol cardiac effect

A

blocks a- and B- adrenoceptors

167
Q

Digoxin oral bioavailability

A

75%

168
Q

Digoxin onset of action

A

1 hour

169
Q

Digoxin duration of action

A

24 hours

170
Q

Digoxin elimination half life

A

36 hours

171
Q

Digoxin excreted unchanged in urine

A

60%

172
Q

Digoxin therapeutic serum level

A

0.5-2 ng/mL

173
Q

Dobutamine onset of action

A

1 minute

174
Q

Dobutamine duration of action

A

<10 minutes

175
Q

Dobutamine elimination half-life

A

2 minutes

176
Q

Dobutamine excreted unchanged in urine

A

0%

177
Q

Milrinone onset of action

A

3 minutes

178
Q

Milrinone duration of action

A

variable

179
Q

Milrinone elimination half life

A

4 hours

180
Q

Milrinone excreted unchanged in urine

A

60%

181
Q

Digoxin common adverse effects

A
  • anorexia
  • nausea and vomiting
  • arrhythmias
  • blurred vision
  • chromatopsia
  • gynecomastia
  • seizures
182
Q

Digoxin common drug interactions

A
  • antacids
  • cholestyramine
  • diltiazem
  • quinidine
  • verapamil
183
Q

Dobutamine common adverse effects

A

excessive vasoconstriction and tachyarrhythmias

184
Q

Dobutamine common drug interactions

A

adrenoceptor agonists and antagonists

185
Q

Milrinone common adverse effects

A
  • arrhythmias
  • hypotension
  • thrombocytopenia
186
Q

Milrinone common drug interactions

A

unknown

187
Q

Thiazide and related diuretics meds

A

hydrochlorothiazide

indapamide

188
Q

Loop diuretics meds

A

ethacrynic acid

furosemide

189
Q

Potassium sparing diuretics meds

A

amiloride
spironolactone
triamterene

190
Q

Osmotic diuretics meds

A

glycerol

mannitol

191
Q

Carbonic anhydrase inhibitors meds

A

acetazolamide

dorzolamide

192
Q

Antidiuretic hormone antagonists meds

A

conivaptan

193
Q

Furosemide oral bioavailability

A

60%

194
Q

Furosemide elimination half life

A

2 hours

195
Q

Furosemide duration of action

A

7 hours oral

2 hours IV

196
Q

Torsemide oral bioavailability

A

80%

197
Q

Torsemide elimination half life

A

3.5 hours

198
Q

Torsemide duration of action

A

7 hours oral

7 hours IV

199
Q

Amiloride oral bioavailability

A

20%

200
Q

Amiloride elimination half life

A

8 hours

201
Q

Amiloride duration of action

A

24 hours oral

202
Q

Spironolactone oral bioavailability

A

65%

203
Q

Spironolactone elimination half life

A

1.5 hours

204
Q

Spironolactone duration of action

A

60 hours oral

205
Q

Triamterene oral bioavailability

A

50%

206
Q

Triamterene elimination half life

A

4 hours

207
Q

Triamterene duration of action

A

14 hours oral

208
Q

Glycerol oral bioavailability

A

95%

209
Q

Glycerol elimination half life

A

0.07 hours

210
Q

Glycerol duration of action

A

1 hour oral

211
Q

Mannitol elimination half life

A

1 hour

212
Q

Mannitol duration of action

A

7 hours IV

213
Q

Acetazolamide oral bioavailability

A

70%

214
Q

Acetazolamide elimination half life

A

7.5 hours

215
Q

Acetazolamide duration of action

A

10 hours oral

216
Q

Dorzolamide duration of action

A

8 hours topical

217
Q

Hydrochlorothiazide common adverse effects

A
  • blood cell deficiencies
  • electrolyte imbalances
  • increased blood cholesterol, glucose, or uric acid levels
218
Q

Hydrochlorothiazide common drug interactions

A

potentiates the diuretic effect of loop diuretics

219
Q

Indapamide common adverse effects

A
  • electrolyte imbalances

- increased blood cholesterol, glucose, or uric acid levels

220
Q

Indapamide common drug interactions

A

potentiates the diuretic effect of loop diuretics

221
Q

Metolazone common adverse effects

A
  • blood cell deficiencies
  • electrolyte imbalances
  • increased blood cholesterol or glucose levels
222
Q

Metolazone common drug interactions

A

potentiates the diuretic effect of loop diuretics

223
Q

Bumetanide common adverse effects

A
  • blood cell deficiencies
  • electrolyte imbalances
  • hearing impairment
  • rash
224
Q

Bumetanide common drug interactions

A
  • diuretic effect decreased by NSAIDs

- administration with ACE inhibitors may cause excessive hypotension

225
Q

Ethacrynic acid common adverse effects

A
  • blood cell deficiencies
  • electrolyte imbalances
  • hearing impairment
  • rash
226
Q

Ethacrynic acid common drug interactions

A

diuretic effect decreased by NSAIDs

227
Q

Furosemide common adverse effects

A
  • blood cell deficiencies
  • electrolyte imbalances
  • hearing impairment
  • hypersensitivity reactions
  • increased blood cholesterol, glucose, or uric acid levels
  • photosensitivity
228
Q

Furosemide common drug interactions

A
  • diuretic effect decreased by NSAIDs

- administration with ACE inhibitors may cause excessive hypotension

229
Q

Torsemide common adverse effects

A
  • electrolyte imbalances

- increased blood cholesterol, glucose, or uric acid levels

230
Q

Torsemide common drug interactions

A
  • diuretic effect decreased by NSAIDs

- administration with ACE inhibitors may cause excessive hypotension

231
Q

Amiloride common adverse effects

A
  • blood cell deficiencies
  • gastrointestinal distress
  • hyperkalemia
232
Q

Amiloride common drug interactions

A
  • administration with ACE inhibitors or potassium supplements may cause hyperkalemia
  • administration with NSAIDs may cause renal failure
233
Q

Spironolactone common adverse effects

A

gynecomastia, hyperkalemia, and impotence

234
Q

Spironolactone common drug interactions

A

administration with ACE inhibitors or potassium supplements may cause hyperkalemia

235
Q

Triamterene common adverse effects

A
  • blood cell deficiencies
  • gastrointestinal distress
  • hyperkalemia
236
Q

Triamterene common drug interactions

A
  • administration with ACE inhibitors or potassium supplements may cause hyperkalemia
  • administration with NSAIDs may cause renal failure
237
Q

Glycerol common adverse effects

A
  • heart failure
  • nausea and vomiting
  • pulmonary congestion and edema
238
Q

Glycerol common drug interanctions

A

potentiates effects of other diuretics

239
Q

Mannitol common adverse effects

A
  • heart failure
  • nausea and vomiting
  • pulmonary congestion and edema
240
Q

Mannitol common drug interactions

A

potentiates effects of other diuretics

241
Q

Acetazolamide common adverse effects

A
  • blood cell deficiencies
  • drowsiness
  • hepatic insufficiency
  • hyperglycemia
  • hypokalemia
  • metabolic acidosis
  • paresthesia
  • uremia
242
Q

Acetazolamide common drug interactions

A
  • serum levels of weak bases are increased by CA inhibitors

- CA inhibitors are increased by salicylates

243
Q

Dorzolamide common adverse effects

A
  • bitter taste
  • blurred vision
  • ocular discomfort
  • allergic reactions
244
Q

Sodium channel blockers meds

A

disopyramide
lidocaine
propafenone

245
Q

Beta Adrenoceptor Blockers med

A

metoprolol

246
Q

Potassium channel blockers meds

A
amiodarone 
dronedarone 
ibutilide 
dofetilide 
sotalol
247
Q

Calcium channel blockers med

A

diltiazem

248
Q

Miscellaneous cardiac dysrhythmias meds

A
adenosine 
digoxin 
magnesium sulfate
ivabradine 
ranolazine
249
Q

Disopyramide oral bioavailability

A

90%

250
Q

Disopyramide onset of action

A

1 hour

251
Q

Disopyramide duration of action

A

6 hours

252
Q

Disopyramide elimination half life

A

7 hours

253
Q

Disopyramide excreted unchanged in urine

A

50%

254
Q

Procainamide oral bioavailability

A

85%

255
Q

Procainamide onset of action

A

1 hour

256
Q

Procainamide duration of action

A

5 hours

257
Q

Procainamide elimination half life

A

3.5 hours

258
Q

Procainamide excretion unchanged in urine

A

55%

259
Q

Quinidine oral bioavailability

A

75%

260
Q

Quinidine onset of action

A

1 hour

261
Q

Quinidine duration of action

A

7 hours

262
Q

Quinidine elimination half life

A

6 hours

263
Q

Quinidine excreted unchanged in urine

A

30%

264
Q

Lidocaine elimination half life

A

1.5 hours

265
Q

Lidocaine excreted unchanged in urine

A

1%

266
Q

Mexiletine oral bioavailability

A

90%

267
Q

Mexiletine onset of action

A

1 hour

268
Q

Mexiletine duration of action

A

10 hours

269
Q

Mexiletine elimination half life

A

11 hours

270
Q

Mexiletine excreted unchanged in urine

A

10%

271
Q

Flecainide oral bioavailability

A

75%

272
Q

Flecainide onset of action

A

3 hours

273
Q

Flecainide duration of action

A

21 hours

274
Q

Flecainide elimination half life

A

14 hours

275
Q

Flecainide excreted unchanged in urine

A

30%

276
Q

Propafenone oral bioavailability

A

10%

277
Q

Propafenone onset of action

A

3 hours

278
Q

Propafenone duration of action

A

10 hours

279
Q

Propafenone elimination half life

A

6 hours

280
Q

Propafenone excreted unchanged in urine

A

<1%

281
Q

Esmolol onset of action

A

<5 minutes

282
Q

Esmolol duration of action

A

20-30 minutes

283
Q

Esmolol elimination half life

A

0.15 hours

284
Q

Esmolol excreted unchanged in urine

A

<2%

285
Q

Metoprolol oral bioavailability

A

35%

286
Q

Metoprolol onset of action

A

1 hour

287
Q

Metoprolol duration of action

A

15 hours

288
Q

Metoprolol elimination half life

A

3.5 hours

289
Q

Metoprolol excreted unchanged in urine

A

7%

290
Q

Propranolol oral bioavailability

A

35%

291
Q

Propranolol onset of action

A

0.5 hour

292
Q

Propranolol duration of action

A

4 hours

293
Q

Propranolol elimination half life

A

4 hours

294
Q

Propranolol excreted unchanged in urine

A

<0.5%

295
Q

Amiodarone oral bioavailability

A

45%

296
Q

Amiodarone onset of action

A

2 weeks

297
Q

Amiodarone duration of action

A

4 weeks

298
Q

Amiodarone elimination half life

A

40 days

299
Q

Amiodarone excreted unchanged in urine

A

0%

300
Q

Dofetilide oral bioavailability

A

90%

301
Q

Dofetilide onset of action

A

1 hour

302
Q

Dofetilide duration of action

A

12 hours

303
Q

Dofetilide elimination half life

A

10 hours

304
Q

Dofetilide excreted unchanged in urine

A

80%

305
Q

Ibutilide onset of action

A

5 minutes

306
Q

Ibutilide elimination half life

A

6 hours

307
Q

Ibutilide excreted unchanged in urine

A

<10%

308
Q

Sotalol oral bioavailability

A

90%

309
Q

Sotalol onset on action

A

2 hours

310
Q

Sotalol duration of action

A

15 hours

311
Q

Sotalol elimination half life

A

12 hours

312
Q

Sotalol excreted unchanged un urine

A

90%

313
Q

Diltiazem oral availability

A

55%

314
Q

Diltiazem onset of action

A

2 hours

315
Q

Diltiazem duration of action

A

8 hours

316
Q

Diltiazem elimination half life

A

5 hours

317
Q

Diltiazem excreted unchanged in urine

A

3%

318
Q

Verapamil oral bioavailability

A

25%

319
Q

Verapamil onset of action

A

2 hours

320
Q

Verapamil duration of action

A

9 hours

321
Q

Verapamil elimination half life

A

5 hours

322
Q

Verapamil excreted unchanged in urine

A

3%

323
Q

Adenosine onset of action

A

30 seconds

324
Q

Adenosine duration of action

A

1.5 minutes

325
Q

Adenosine elimination half life

A

<10 seconds

326
Q

Adenosine excreted unchanged in urine

A

0%

327
Q

Digoxin oral bioavailability

A

75%

328
Q

Digoxin onset of action

A

1 hour

329
Q

Digoxin duration of action

A

24 hours

330
Q

Digoxin elimination half life

A

35 hours

331
Q

Digoxin excreted unchanged in urine

A

60%

332
Q

Magnesium onset of action

A

<5 minutes

333
Q

Magnesium sulfate excreted unchanged in urine

A

100%